Specificity and sensitivity of transcranial sonography of the substantia nigra in the diagnosis of Parkinson's disease: Prospective cohort study in 196 patients

BMJ Open

Volumn 3, Issue 4, 2013, Pages

  Bouwmans, Angela E P ^a   Vlaar, Annemarie M M ^b   Mess, Werner H ^a   Kessels, Alfons ^a   Weber, Wim E J ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IOFLUPANE I 123;

AGED; ARTICLE; BRAIN ATROPHY; CLINICAL TRIAL; DEMENTIA; DIAGNOSTIC ACCURACY; ESSENTIAL TREMOR; FEMALE; GOLD STANDARD; HOSPITAL; HUMAN; LEWY BODY; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MOTOR DYSFUNCTION; NERVE DEGENERATION; NETHERLANDS; OUTPATIENT; PARALYSIS; PARKINSON DISEASE; PARKINSONISM; PATIENT REFERRAL; PHOTON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUBSTANTIA NIGRA; TEACHING HOSPITAL; ULTRASOUND;

EID: 84877707641     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-002613     Document Type: Article

References (62)

1. Kalra S, Grosset DG, Benamer HT. Differentiating vascular parkinsonism from idiopathic Parkinson's disease: a systematic review. Mov Disord 2010;25:149-56.
2. Diaz-Corrales FJ, Sanz-Viedma S, Garcia-Solis D, et al. Clinical features and 123I-FP-CIT SPECT imaging in drug-induced parkinsonism and Parkinson's disease. Eur J Nucl Med Mol Imaging 2010;37:556-64.
3. Wenning GK, Ben-Shlomo Y, Hughes A, et al. What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease? J Neurol Neurosurg Psychiatry 2000;68:434-40. (Pubitemid 30248742)
4. Osaki Y, Ben-Shlomo Y, Lees AJ, et al. Accuracy of clinical diagnosis of progressive supranuclear palsy. Mov Disord 2004;19:181-9. (Pubitemid 38312700)
5. Litvan I, Agid Y, Goetz, et al. Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. Neurology 1997;48:119-25. (Pubitemid 27039529)
6. Wadia PM, Lang AE. The many faces of corticobasal degeneration. Parkinsonism Relat Disord 2007;13(Suppl 3):S336-40. (Pubitemid 351215265)
7. Litvan I, MacIntyre A, Goetz CG, et al. Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study. Arch Neurol 1998;55:969-78. (Pubitemid 28335116)
8. Cardoso F, Camargos ST, Silva GA Jr. Eiology of parkinsonism in a Brazilian movement disorders clinic. Arq Neuropsiquiatr 1998;56:171-5. (Pubitemid 28277641)
9. Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-4.
10. Munhoz RP, Werneck LC, Teive HA. The differential diagnoses of parkinsonism: findings from a cohort of 1528 patients and a 10 years comparison in tertiary movement disorders clinics. Clin Neurol Neurosurg 2010;112:431-5.
11. Newman EJ, Breen K, Patterson J, et al. Accuracy of Parkinson's disease diagnosis in 610 general practice patients in the West of Scotland. Mov Disord 2009;24:2379-85.
12. Rajput DR. Accuracy of clinical diagnosis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1993;56:938-9. (Pubitemid 23246166)
13. Ahlskog JE. Diagnosis and differential diagnosis of Parkinson's disease and parkinsonism. Parkinsonism Relat Disord 2000;7:63-70.
14. Caslake R, Moore JN, Gordon JC, et al. Changes in diagnosis with follow-up in an incident cohort of patients with parkinsonism. J Neurol Neurosurg Psychiatry 2008;79:1202-7.
15. Marshall VL, Reininger CB, Marquardt M, et al. Parkinson's disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: a 3-year European multicenter study with repeat [123I] FP-CIT SPECT. Mov Disord 2009;24:500-8.
16. McKinnon JH, Demaerschalk BK, Caviness JN, et al. Sniffing out Parkinson disease: can olfactory testing differentiate parkinsonian disorders? Neurologist 2007;13:382-5. (Pubitemid 350307683)
17. Katzenschlager R, Lees AJ. Olfaction and Parkinson's syndromes: its role in differential diagnosis. Curr Opin Neurol 2004;17:417-23. (Pubitemid 39071417)
18. Brooks DJ. Imaging approaches to Parkinson disease. J Nucl Med 2010;51:596-609.
19. Vlaar AM, van Kroonenburgh MJ, Kessels AG, et al. Meta-analysis of the literature on diagnostic accuracy of SPECT in parkinsonian syndromes. BMC Neurol 2007;7:27.
20. Piccini P, Whone A. Functional brain imaging in the differential diagnosis of Parkinson's disease. Lancet Neurol 2004;3:284-90. (Pubitemid 38510199)
21. Walter U, Wittstock M, Benecke R, et al. Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease. J Neural Transm 2002;109:191-6. (Pubitemid 34185665)
22. Berg D, Siefker C, Becker G. Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings. J Neurol 2001; 248: 684-9. (Pubitemid 32695865)
23. Ressner P, Skoloudík D, Hlustík P, et al. Hyperechogenicity of the substantia nigra in Parkinson's disease. J Neuroimaging 2007;17:164-7. (Pubitemid 46624157)
24. Huang YW, Jeng JS, Tsai CF, et al. Transcranial imaging of substantia nigra hyperechogenicity in a Taiwanese cohort of Parkinson's disease. Mov Disord 2007;22:550-5.
25. Spiegel J, Hellwig D, Möllers MO, et al. Transcranial sonography and [123I]FP-CIT SPECT disclose complementary aspects of Parkinson's disease. Brain 2006;129(Pt 5):1188-93.
26. Becker G, Seufert J, Bogdahn U, et al. Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography. Neurology 1995;45:182-4.
27. Berg D, Becker G, Zeiler B, et al. Vulnerability of the nigrostriatal system as detected by transcranial ultrasound. Neurology 1999; 53: 1026-31. (Pubitemid 29442119)
28. Berg D, Roggendorf W, Schröder U, et al. Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol 2002;59:999-1005. (Pubitemid 34640761)
29. Kim JY, Kim ST, Jeon SH, et al. Midbrain transcranial sonography in Korean patients with Parkinson's disease. Mov Disord 2007;22:1922-6.
30. Gaenslen A, Unmuth B, Godau J, et al. The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: a prospective blinded study. Lancet Neurol 2008;7:417-24.
31. Berg D, Merz B, Reiners K, et al. Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease. Mov Disord 2005; 20: 383-5. (Pubitemid 40613305)
32. Walter U, Dressler D, Wolters A, et al. Transcranial brain sonography findings in clinical subgroups of idiopathic Parkinson's disease. Mov Disord 2007;22:48-54. (Pubitemid 46382672)
33. Walter U, Skoloudik D, Berg D. Transcranial sonography findings related to non-motor features of Parkinson's disease. J Neurol Sci 2010;289:123-7.
34. Schweitzer KJ, Hilker R, Walter U, et al. Substantia nigra hyperechogenicity as a marker of predisposition and slower progression in Parkinson's disease. Mov Disord 2006;21:94-8. (Pubitemid 43273759)
35. Weise D, Lorenz R, Schliesser M, et al. Substantia nigra echogenicity: a structural correlate of functional impairment of the dopaminergic striatal projection in Parkinson's disease. Mov Disord 2009;24:1669-75.
36. Prestel J, Schweitzer KJ, Hofer A, et al. Predictive value of transcranial sonography in the diagnosis of Parkinson's disease. Mov Disord 2006;21:1763-5. (Pubitemid 44742216)
37. Hagenah JM, König IR, Becker B, et al. Substantia nigra hyperechogenicity correlates with clinical status and number of Parkin mutated alleles. J Neurol 2007;254:1407-13. (Pubitemid 350112333)
38. Mehnert S, Reuter I, Schepp K, et al. Transcranial sonography for diagnosis of Parkinson's disease. BMC Neurol 2010;10:9.
39. Walter U, Niehaus L, Probst T, et al. Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes. Neurology 2003;60:74-7. (Pubitemid 36070647)
40. Walter U, Dressler D, Probst T, et al. Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease. Arch Neurol 2007;64:1635-40. (Pubitemid 350106766)
41. Behnke S, Berg D, Naumann M, et al. Differentiation of Parkinson's disease and atypical parkinsonian syndromes by transcranial ultrasound. J Neurol Neurosurg Psychiatry 2005;76:423-5. (Pubitemid 40299138)
42. Okawa M, Miwa H, Kajimoto Y, et al. Transcranial sonography of the substantia nigra in Japanese patients with Parkinson's disease or atypical parkinsonism: clinical potential and limitations. Intern Med 2007;46:1527-31. (Pubitemid 47521048)
43. Ebentheuer J, Canelo M, Trautmann E, et al. Substantia nigra echogenicity in progressive supranuclear palsy. Mov Disord 2010;25:765-8.
44. Lauckaite K, Rastenyte D, Šurkiene D, et al. Specificity of transcranial sonography in parkinson spectrum disorders in comparison to degenerative cognitive syndromes. BMC Neurol 2012;12:12.
45. Tsai CF, Wu RM, Huang YW, et al. Transcranial color-coded sonography helps differentiation between idiopathic Parkinson's disease and vascular parkinsonism. J Neurol 2007;254:501-7.
46. Doepp F, Plotkin M, Siegel L, et al. Brain parenchyma sonography and 123I-FP-CIT SPECT in Parkinson's disease and essential tremor. Mov Disord 2008;23:405-10.
47. Budisic M, Trkanjec Z, Bosnjak J, et al. Distinguishing Parkinson's disease and essential tremor with transcranial sonography. Acta Neurol Scand 2009;119:17-21.
48. Stockner H, Sojer M, K KS, et al. Midbrain sonography in patients with essential tremor. Mov Disord 2007;22:414-17. (Pubitemid 46569702)
49. Walter U, Dressler D, Wolters A, et al. Sonographic discrimination of dementia with Lewy bodies and Parkinson's disease with dementia. J Neurol 2006;253:448-54. (Pubitemid 43965609)
50. Walter U, Dressler D, Wolters A, et al. Sonographic discrimination of corticobasal degeneration vs progressive supranuclear palsy. Neurology 2004;63:504-9. (Pubitemid 39031381)
51. Bouwmans AE, Vlaar AM, Srulijes K, et al. Transcranial sonography for the discrimination of idiopathic Parkinson's disease from the atypical parkinsonian syndromes. Int Rev Neurobiol 2010;90:121-46.
52. Vlaar AM, Bouwmans AE, van Kroonenburgh MJ, et al. Protocol of a prospective study on the diagnostic value of transcranial duplex scanning of the substantia nigra in patients with parkinsonian symptoms. BMC Neurol 2007;7:28.
53. Berg D, Godau J, Walter U. Transcranial sonography in movement disorders. Lancet Neurol 2008; 7: 1044-55.
54. Vlaar A, Tromp SC, Weber WE, et al. The reliability of transcranial duplex scanning in parkinsonian patients: comparison of different observers and ultrasound systems. Ultraschall Med 2011; 32:S83-8.
55. Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease. The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations. Mov Disord 2003;18:738-50.
56. Gilman S, Wenning GK, Low PA, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008;71:670-6.
57. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996;47:1-9. (Pubitemid 26243849)
58. McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005;65:1863-72. (Pubitemid 43970103)
59. Mahapatra RK, Edwards MJ, Schott JM, et al. Corticobasal degeneration. Lancet Neurol 2004;3:736-43. (Pubitemid 39535259)
60. Vlaar AM, de Nijs T, van Kroonenburgh MJ, et al. The predictive value of transcranial duplex sonography for the clinical diagnosis in undiagnosed parkinsonian syndromes: comparison with SPECT scans. BMC Neurol 2008;8:42.
61. Bachmann LM, ter Riet G, Weber WE, et al. Multivariable adjustments counteract spectrum and test review bias in accuracy studies. J Clin Epidemiol 2009;62:357-361 e2.
62. van de Loo S, Walter U, Behnke S, et al. Reproducibility and diagnostic accuracy of substantia nigra sonography for the diagnosis of Parkinson's disease. J Neurol Neurosurg Psychiatry 2010;81:1087-92.